Wilson's disease is a rare and serious genetic disorder affecting copper metabolism in the body, leading to excessive accumulation of copper in the liver, brain, and other organs. This can cause a wide range of serious health problems, including liver cirrhosis, neurological problems, and kidney disease. Wilson's disease is caused by a genetic defect which affects the transport of copper in the body. Individuals with this disorder have a genetic mutation which means their liver is unable to excrete copper effectively. This leads to a build up of copper in the body, and it accumulates to toxic levels in certain organs. Even though Wilson's disease is a rare condition, its diagnosis can be improved through screening for genetic mutations associated with this disorder. In such cases, early diagnosis with the right treatment can be curative and the prognosis is often good. Treatment typically involves the use of medications which prevent the absorption of copper from food and chelation therapy, in which drugs bind to copper in the body so it can be eliminated in the urine. Lifestyle changes may also be beneficial, such as avoiding foods high in copper content, Vitamins C and B6, caffeine, and alcohol, as well as exercising regularly and avoiding extreme stress. Living with Wilson's disease can be challenging, as it can lead to severe physical and psychological effects. Many people with this condition, however, live normal and productive lives with the help of continuous medication, nutrition, and medication monitoring. Overall, Wilson's disease is a rare but serious disorder, but with the right treatment and support, it can be managed to maintain a healthy, happy life.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom